SCANGOS GEORGE A 4
4 · Vir Biotechnology, Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
SCANGOS GEORGE A
Director
Transactions
- Award
Common Stock
2024-05-30+8,000→ 120,989 total - Award
Stock Option (Right to Buy)
2024-05-30+16,000→ 16,000 totalExercise: $10.39From: 2025-05-30Exp: 2034-05-29→ Common Stock (16,000 underlying)
Holdings
- 1,750,000(indirect: See footnote)
Common Stock
- 1,750,000(indirect: See footnote)
Common Stock
- 33,629(indirect: See footnote)
Common Stock
- 179,930(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F2]The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F3]The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
- [F4]The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.